Point Of Care Glucose Testing Market Size, Share and Forecast Trends - Growth Analysis and Outlook Report 2026-2030

The POC glucose testing market encompasses devices and consumables that deliver rapid blood glucose readings at or near the site of patient care, bypassing traditional central lab processing. The market's valuation of $3.87 billion reflects combined revenue from test strips, glucose meters, continuous glucose monitoring systems, and related accessories across hospital, clinic, retail pharmacy, and homecare settings. Unlike laboratory analyzers, POC devices emphasize convenience, speed, and immediate clinical decision-making, making them essential tools for managing the estimated 537 million adults living with diabetes worldwide.

• •Market valued at approximately $3.87 billion globally in 2025
• •Encompasses glucose meters, test strips, lancets, and continuous glucose monitoring systems
• •Serves hospital, clinic, retail, and homecare settings

The primary engine of market expansion is the escalating global diabetes epidemic, with the International Diabetes Federation projecting over 643 million people living with diabetes by 2030. Simultaneously, technological advances have produced smaller, more accurate devices with connectivity features, enabling data sharing with healthcare providers and integration with mobile health applications. Cost-containment pressures on healthcare systems also favor POC testing, as early detection and patient self-management reduce complications and hospital admissions.

• •Rising global prevalence of diabetes and prediabetes conditions
• •Advancements in sensor technology and digital health connectivity
• •Healthcare cost reduction incentives favoring early and home-based testing

The market divides by product type into traditional glucose meters, test strips, lancets, and continuous and flash glucose monitoring systems, with CGM/FGM segments growing fastest due to improved patient adherence and reimbursement support. Geographically, North America leads due to high diabetes prevalence and favorable reimbursement policies, while Asia-Pacific represents the fastest-growing region driven by rising healthcare access and expanding middle-class populations in India and China.

• •Continuous glucose monitoring segment outpacing traditional meter and strip sales
• •North America holds the largest regional share with robust insurance coverage
• •Asia-Pacific emerging as the fastest-growing market due to rising diabetes rates

What are the recent trends and outlook?

The integration of artificial intelligence and machine learning into glucose monitoring is accelerating, with next-generation devices capable of predictive hypoglycemia and hyperglycemia alerts. Multi-analyte POC devices combining glucose with HbA1c or ketone testing are gaining clinical traction, while telehealth adoption since the COVID-19 pandemic has normalized remote glucose data sharing. Looking ahead, the market is expected to sustain a compound annual growth rate near 4.6%, approaching an estimated $4.9 to $5.1 billion by 2030, supported by ongoing miniaturization, regulatory approvals for over-the-counter CGM devices, and expanding healthcare infrastructure in emerging economies.

• •AI-powered predictive analytics and multi-analyte POC devices gaining clinical adoption
• •Telehealth and remote patient monitoring driving demand for connected glucose devices
• •Projected market value approaching $5 billion by 2030 at continued 4.6% CAGR